Breast cancer is the second most common type of cancer, the fifth most common cause of cancer deaths in the US and the world, and the most common cause of cancer death in women. Knowing the accurate stage of the breast cancer is critical for patient survival. Sufficient treatment during the early stages of breast cancer can prevent the spread and transfer of the cancer cells to other parts of the body. But, the cancer cells need to be diagnosed at the early stage in order to start treatment. We report the development of early stage detection of breast cancer cells using quantum dots (QDs) as fluorescent signal generator for detection. The QDs based imaging of breast cancer cells involved two kinds of antibodies: the first was for labeling the cells and the second was for imaging the breast cancer cells. Anti-Her2/neu (1 0 Ab) was used for labeling the captured SK-BR3 cells. The second antibody against antiHer2/neu (2 0 Ab) that was conjugated to QDs (2 0 Ab~QDs) forms the complete assay, SK-BR3 + 1 0 Ab + 2 0 Ab~QDs, to generate the fluorescent cells for imaging. Fluorescent images of the complete assay for SK-BR3 cells were evaluated under a microscope with a UV light source. The preliminary results showed that the breast cancer cell SK-BR3 in the complete assay were successfully observed as fluorescent cells that had brighter signals compared with those labeled with organic dye using similar parameters and the same number of cells. Future directions will involve elimination of non-specific signals, establishment of dynamic range of concentrations detected as well as limits of detection, and multiplex detection of different types cells and/or biomarkers of cancer.